dc.contributor.author
Meisl, Christina J.
dc.contributor.author
Karakiewicz, Pierre I.
dc.contributor.author
Einarsson, Roland
dc.contributor.author
Koch, Stefan
dc.contributor.author
Hallmann, Steffen
dc.contributor.author
Weiß, Sarah
dc.contributor.author
Hemdan, Tammer
dc.contributor.author
Malmström, Per‐Uno
dc.contributor.author
Styrke, Johan
dc.contributor.author
Sherif, Amir
dc.contributor.author
Hasan, Mudhar N.
dc.contributor.author
Pichler, Renate
dc.contributor.author
Tulchiner, Gennadi
dc.contributor.author
Palou, Joan
dc.contributor.author
Rodríguez Faba, Óscar
dc.contributor.author
Hennenlotter, Jörg
dc.contributor.author
Stenzl, Arnulf
dc.contributor.author
Ritter, René
dc.contributor.author
Niegisch, Günter
dc.contributor.author
Grunewald, Camilla M.
dc.contributor.author
Schlomm, Thorsten
dc.contributor.author
Friedersdorff, Frank
dc.contributor.author
Barski, Dimitri
dc.contributor.author
Otto, Thomas
dc.contributor.author
Gössl, Andreas
dc.contributor.author
Arndt, Christian
dc.contributor.author
Esuvaranathan, Kesavan
dc.contributor.author
Kesavan, Nisha R.
dc.contributor.author
Zhijiang, Zang
dc.contributor.author
Kramer, Mario W.
dc.contributor.author
Hennig, Martin J. P.
dc.contributor.author
Ecke, Thorsten H.
dc.date.accessioned
2022-12-06T14:41:15Z
dc.date.available
2022-12-06T14:41:15Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/37189
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-36902
dc.description.abstract
Objectives: To evaluate the clinical utility of the urinary bladder cancer antigen test UBC Rapid for the diagnosis of bladder cancer (BC) and to develop and validate nomograms to identify patients at high risk of primary BC.
Patients and Methods: Data from 1787 patients from 13 participating centres, who were tested between 2012 and 2020, including 763 patients with BC, were analysed. Urine samples were analysed with the UBC Rapid test. The nomograms were developed using data from 320 patients and externally validated using data from 274 patients. The diagnostic accuracy of the UBC Rapid test was evaluated using receiver-operating characteristic curve analysis. Brier scores and calibration curves were chosen for the validation. Biopsy-proven BC was predicted using multivariate logistic regression.
Results: The sensitivity, specificity, and area under the curve for the UBC Rapid test were 46.4%, 75.5% and 0.61 (95% confidence interval [CI] 0.58–0.64) for low-grade (LG) BC, and 70.5%, 75.5% and 0.73 (95% CI 0.70–0.76) for high-grade (HG) BC, respectively. Age, UBC Rapid test results, smoking status and haematuria were identified as independent predictors of primary BC. After external validation, nomograms based on these predictors resulted in areas under the curve of 0.79 (95% CI 0.72–0.87) and 0.95 (95% CI: 0.92–0.98) for predicting LG-BC and HG-BC, respectively, showing excellent calibration associated with a higher net benefit than the UBC Rapid test alone for low and medium risk levels in decision curve analysis. The R Shiny app allows the results to be explored interactively and can be accessed at www.blucab-index.net.
Conclusion: The UBC Rapid test alone has limited clinical utility for predicting the presence of BC. However, its combined use with BC risk factors including age, smoking status and haematuria provides a fast, highly accurate and non-invasive tool for screening patients for primary LG-BC and especially primary HG-BC.
en
dc.rights.uri
https://creativecommons.org/licenses/by-nc/4.0/
dc.subject
bladder cancer
en
dc.subject
logistic model
en
dc.subject
UBC (R) Rapid test
en
dc.subject
urothelial cancer
en
dc.subject
#BladderCancer
en
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit
dc.title
Nomograms including the UBC® Rapid test to detect primary bladder cancer based on a multicentre dataset
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation.doi
10.1111/bju.15677
dcterms.bibliographicCitation.journaltitle
BJU International
dcterms.bibliographicCitation.number
6
dcterms.bibliographicCitation.originalpublishername
Wiley
dcterms.bibliographicCitation.pagestart
754
dcterms.bibliographicCitation.pageend
763
dcterms.bibliographicCitation.volume
130
refubium.affiliation
Charité - Universitätsmedizin Berlin
refubium.funding
DEAL Wiley
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.bibliographicCitation.pmid
34928524
dcterms.isPartOf.issn
1464-4096
dcterms.isPartOf.eissn
1464-410X